Asset
OMECAMTIV MECARBIL
Cytokinetics Incorporated Common Stock
Revenue
No revenue reported in loaded filings.
Clinical trials (4)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT00624442 | phase2 | completed | 2007-04-01 | 2009-02-01 | Cytokinetics | A Study of CK-1827452 Infusion in Stable Heart Failure |
| NCT00682565 | phase2 | completed | 2008-04-01 | 2008-11-01 | Cytokinetics | PK and Tolerability of IV and Oral CK-1827452 in Patients With Ischemic Cardiomyopathy and Angina |
| NCT00941681 | phase2 | completed | 2009-04-01 | 2009-10-01 | Cytokinetics | Pharmacokinetics of Oral CK-1827452 in Patients With Stable Heart Failure |
| NCT00748579 | phase2 | terminated | 2008-09-01 | 2008-11-01 | Cytokinetics | Phase II Study of the Effect of CK-1827452 Injection on Myocardial Efficiency |
FDA applications (0)
This company has no applications containing this asset.